Anthony Hunt Repligen Corp (RGEN) insider trading activity

Anthony Hunt is of REPLIGEN CORP. Currently has a direct ownership of 139,840 shares of RGEN, which is worth approximately $19.9 Million. The most recent transaction as insider was on Sep 08, 2022, when has been sold 26,402 shares (Common Stock) at a price of $223.76 per share, resulting in proceeds of $5,907,711. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 140K

15.34% 3M change

28.03% 12M change

Total Value Held $19.9 Million

Anthony Hunt Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 08 2022	SELL Open market or private sale	$5,907,711 $223.76 p/Share	26,402 Reduced 12.9%	178,265 Common Stock
Sep 08 2022	BUY Exercise of conversion of derivative security	$338,700 $33.87 p/Share	10,000 Added 4.66%	204,667 Common Stock
Jul 21 2022	SELL Open market or private sale	$4,960,400 $200.0 p/Share	24,802 Reduced 11.3%	194,667 Common Stock
Jul 21 2022	BUY Exercise of conversion of derivative security	$667,904 $33.14 p/Share	20,154 Added 8.41%	219,469 Common Stock
Mar 01 2022	SELL Payment of exercise price or tax liability	$1,415,086 $194.06 p/Share	7,292 Reduced 3.53%	199,315 Common Stock
Feb 28 2022	SELL Payment of exercise price or tax liability	$3,253,025 $196.7 p/Share	16,538 Reduced 7.41%	206,607 Common Stock
Feb 28 2022	BUY Grant, award, or other acquisition	-	30,074 Added 12.03%	219,975 Common Stock
Feb 27 2022	SELL Payment of exercise price or tax liability	$541,712 $196.7 p/Share	2,754 Reduced 1.41%	193,071 Common Stock
Feb 24 2022	SELL Payment of exercise price or tax liability	$221,376 $189.21 p/Share	1,170 Reduced 0.59%	195,825 Common Stock
Feb 24 2022	BUY Grant, award, or other acquisition	-	15,855 Added 7.45%	196,995 Common Stock
Nov 18 2021	SELL Open market or private sale	$4,811,153 $277.22 p/Share	17,355 Reduced 8.7%	182,140 Common Stock
Nov 18 2021	SELL Exercise of conversion of derivative security	$324,000 $32.4 p/Share	10,000 Reduced 4.77%	199,495 Common Stock
Sep 09 2021	SELL Open market or private sale	$7,386,250 $295.45 p/Share	25,000 Reduced 11.66%	189,495 Common Stock
Sep 09 2021	BUY Exercise of conversion of derivative security	$810,000 $32.4 p/Share	25,000 Added 10.44%	214,495 Common Stock
Aug 17 2021	SELL Bona fide gift	-	1,000 Reduced 0.52%	189,495 Common Stock
May 19 2021	SELL Open market or private sale	$3,826,139 $171.83 p/Share	22,267 Reduced 10.47%	190,495 Common Stock
Mar 12 2021	SELL Open market or private sale	$1,739,483 $191.11 p/Share	9,102 Reduced 4.1%	212,762 Common Stock
Mar 04 2021	SELL Open market or private sale	$4,193,412 $191.48 p/Share	21,900 Reduced 8.98%	221,864 Common Stock
Feb 24 2021	BUY Grant, award, or other acquisition	-	10,437 Added 4.11%	243,764 Common Stock
Nov 19 2020	SELL Open market or private sale	$3,722,400 $186.12 p/Share	20,000 Reduced 7.89%	233,327 Common Stock
Nov 19 2020	BUY Exercise of conversion of derivative security	$521,000 $26.05 p/Share	20,000 Added 7.32%	253,327 Common Stock

Also insider at

MASS

908 Devices Inc. Healthcare

Anthony Hunt

Waltham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RGEN shares.

Notify only if

Value

Insider Trading

Get notified when an Repligen Corp insider buys or sells RGEN shares.

Notify only if

Operation

Value

Type

News

Receive news related to REPLIGEN CORP

Track Activities on RGEN

Account